(Q71784422)
Statements
Phase III trial (E5592) comparing cisplatin plus etoposide with cisplatin plus paclitaxel at two dose levels for treatment of advanced non-small-cell lung cancer. Eastern Cooperative Oncology Group (English)
scientific article published on 01 January 1995
No description defined